Jennifer Doudna

There's already a lot of active research going on using the Crispr technology to fix diseases like Duchenne muscular dystrophy or cystic fibrosis or Huntington's disease. They're all diseases that have known genetic causes, and we now have the technology that can repair those mutations to provide, we hope, patients with a normal life.

One of the problems in the biotech world is the lack of women in leadership roles, and I'd like to see that change by walking the walk.